
According to a recent study, medicinal marijuana users are more likely to consume nicotine products than the general population.
According to a news release from Rutgers University, this study was published in the American Journal of Addiction and is one of the first studies to investigate nicotine use among medical marijuana patients.
Mary Bridgeman, a clinical professor at the Ernest Mario School of Pharmacy at Rutgers, stated that there is growing concern over simultaneous use of marijuana and nicotine. While the link between recreational use of marijuana and nicotine has been established, there is little understanding about the use of nicotine among medical marijuana users.
Researchers conducted a survey of 697 patients aged 18 to 89 at a medical cannabis dispensary, inquiring about their use of nicotine and cannabis, how they administer cannabis (smoking, vaping), and their medical conditions for which they use therapeutic cannabis.
They discovered that nearly 40% of medical marijuana users also use nicotine - much higher than the 14% of adult Americans who smoke.
Therapeutic marijuana users who also use e-cigarettes or do not use nicotine at all have about four times the likelihood of using marijuana compared to those who only smoke cigarettes.
The study further revealed that 75% of the respondents reported using marijuana instead of vaping, and approximately 80% of smokers stated they planned to quit smoking in the next six months.
The author of the study, Professor of Psychiatry from Rutgers Robert Wood Johnson Medical School, and co-author Mark Steenberg stated, "These findings suggest that while medical marijuana may present health issues associated with combustible products, recommending e-cigarettes over smoking marijuana alone may not have an impact on patients who also smoke.
Steinberg explained, "These individuals are also seeking to quit traditional cigarettes but need to continue consuming nicotine. This fact provides a strong argument for pharmacies to provide tobacco control information at point of sale to encourage smokers to quit." "This strategy could also increase the likelihood of medical marijuana users switching to e-cigarettes, which is a less harmful alternative to smoking.
Statement:
This article is compiled from third-party information and is intended for industry exchange and learning purposes only.
This article does not represent the views of 2FIRSTS and 2FIRSTS is unable to confirm the truth or accuracy of the content. The translation of this article is solely for the purpose of industry exchange and research.
Due to limitations in our translation ability, the translated article may not fully express the intended meaning of the original. Please refer to the original article for accuracy.
In regards to any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and stances, 2FIRSTS aligns completely with the Chinese government.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.









